By using ZADA Pharmaceuticals business policy, it is defined that the company will produce medicines as a result of its own research and development, as well as, that the production portfolio will be constantly improved with new molecules whose implementation in therapy will be supported by proofs.
The main objective of the research and development policy of ZADA Pharmaceuticals is the development of its formulations and technical methods used for the production of generic medicines together with added values.
The same approach is used when developing formulations for food supplements which are united under the brand named MAXIMA.
The added value to our products is given by the modern and innovative technology, the newest raw materials incorporated into formulations, the experience of experts, and the enthusiasm of young staff engaged in development and production. Production development requires continuous monitoring and implementation of regulatory requirements with the aim of registration and release of high-quality, safe and efficient medicine sets on the market.